A blocking peptide containing 14 amino acids near the amino terminus of human LXR-B.
Points forts
Source
Synthetic
(Accession #: P55055) The LXR beta/NR1H2 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-085489 |
|---|
| Réf. fabricant | 18265017 |
|---|
| Gene ID (Entrez) | 7376 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76256. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | Liver x receptor beta, LXR-b, NER-I, NERliver x receptor-beta, nuclear orphan receptor LXR-beta, Nuclear receptor NER, Nuclear receptor subfamily 1 group H member 2, nuclear receptor subfamily 1, group H, member 2, oxysterols receptor LXR-beta, RIP15, steroid hormone-nuclear receptor NER, Ubiquitously-expressed nuclear receptorLXRB, UNRLX receptor beta |
|---|
| Symbole de gène(s) | NR1H2 |
|---|
| Type de produit | LXR beta/NR1H2 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 14 amino acids near the amino terminus of human LXR-B |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
